Pathogenesis, diagnosis and treatment of atherosclerosis: practical aspects

Sergienko I.V.; Ansheles A.A.

doi:https://doi.org/10.17116/Cardiobulletin20211601164

Sergienko I.V.

National Medical Research Center of Cardiology

Ansheles A.A.

Chazov National Medical Research Center of Cardiology

ORCID: 0000-0002-2675-3276

Pathogenesis, diagnosis and treatment of atherosclerosis: practical aspects

Authors:

Sergienko I.V., Ansheles A.A.

More about the authors

Journal: Russian Cardiology Bulletin. 2021;16(1): 64‑72

DOI: 10.17116/Cardiobulletin20211601164

Read: 13107 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Sergienko IV, Ansheles AA. Pathogenesis, diagnosis and treatment of atherosclerosis: practical aspects. Russian Cardiology Bulletin. 2021;16(1):64‑72. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20211601164

Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Giant popliteal artery aneurysm. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):115-119

Potential for the use of nutraceuticals for hyperlipidemia correction. Russian Journal of Preventive Medicine. 2025;(3):40-45

Increased expression of circular RNA circSPARC and circTMEM181 in coronary atherosclerosis. Molecular Genetics, Microbiology and Virology. 2025;(1):24-29

The influence of demographic factors and major comorbidities on serum circulating regulatory microRNAs in patients with coronary artery atherosclerosis and thoracic aortic aneurysm: a single-center cohort study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):174-182

The place of non-high-density lipoprotein cholesterol and triglycerides in the assessment of cardiovascular risk: Resolution of the Panel of Experts. Russian Journal of Preventive Medicine. 2025;(4):7-15

Neutrophil elastase as a promising biomarker of low-grade inflammation in chronic non-communicable diseases. Russian Journal of Preventive Medicine. 2025;(4):142-148

Features of care of patients with cardiovascular diseases and cognitive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):99-104

Comparison of the results of autovenous bypass surgery on the anterior tibial artery depending on access choice. Pirogov Russian Journal of Surgery. 2025;(7):5-10

Potential and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medicine. 2025;(7):94-99

Intercellular adhesion proteins: P-, E-, H-cadherins as oncological and cardiovascular diseases’ biomarkers. Russian Journal of Preventive Medicine. 2025;(7):100-105

Abstract:

The authors report the abstracts from the 4^th edition of the monograph «Dyslipidemias, Atherosclerosis and Coronary Artery Disease» devoted to pathogenesis, risk factors, diagnosis and therapy of atherosclerosis and dyslipidemias. New changes are incorporated in the VII version of the RNAS guidelines and include the introduction of an extremely high-risk patients, correction of LDL-C target values, another interpretation of SCORE values, emphasis on various phenotypes of atherosclerosis, comorbidity and multimorbidity, as well as wider use of PCSK9 inhibitors in lipid lowering therapy.

Keywords:

atherosclerosis

practical guidelines

Authors:

Sergienko I.V.

National Medical Research Center of Cardiology

Ansheles A.A.

Chazov National Medical Research Center of Cardiology

ORCID: 0000-0002-2675-3276

Received:

26.05.2020

Accepted:

30.09.2020

Close metadata

References:

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group 2016. European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal. 2016;37(29):2315-2381. https://doi.org/10.1093/eurheartj/ehw106
Sergienko IV, Ansheles AA, Kukharchuk VV. Dislipidemii, ateroskleroz i ishemicheskaya bolezn’ serdca. Genetika, patogenez, fenotipy, diagnostika, terapiya, komorbidnost’. Izdanie chetvertoe, pererabotannoe i dopolnennoe. M.: Patiss; 2020. (In Russ.).
Kuharchuk VV, Ezhov MV, Sergienko IV, Arabidze GG, Bubnova MG, Balahonova TV, Gurevich VS, Kachkovskij MA, Konovalov GA, Konstantinov VO, Malyshev PP, Pokrovskij SD, Sokolov AA, Sumarokov AB, Gornyakova NB, Obrezan AG, Shaposhnik II, Anciferov MB, Ansheles AA, Aronov DM, Ahmedzhanov NM, Barbarash OL, Bojcov SA, Voevoda MI, Galstyan GR, Galyavich AS, Drapkina OM, Duplyakov DV, Eregin SYa, Karpov RS, Karpov YuA, Koziolova NA, Kosmachev ED, Nebieridze DV, Nedogoda SV, Olejnikov VE, Ragino YuI, Skibickij VV, Smolenskaya OG, Filippov AE, Halimov YuSh, Chazova IE, Shestakova MV, Yakushin SS. Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis. Russian recommendations. VII revision. Ateroskleroz i dislipidemii. 2020;38(1):7-40. (In Russ.). https://doi.org/10.34687/2219-8202.JAD.2020.01.0002
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111-188. https://doi.org/10.1093/eurheartj/ehz455
Sergienko IV, Shestakova MV, Boytsov SA, Kukharchuk VV, Zateishchikov DA, Ezhov MV, Gurevich VS, Galyavich AS, Ametov AS, Voevoda MI, Duplyakov DV, Barbarash OL, Halimov YuSh, Antsiferov MB, Arutyunov GP, Ansheles AA, Samorodskaya IV, Drapkina OM. Extreme risk category in the system of stratification of cardiovascular complications. Expert Council Consensus. Ateroskleroz i dislipidemii. 2018;33(4):8-16. (In Russ.).
Sadowitz B, Maier KG, Gahtan V. Basic science review: Statin therapy — Part I: The pleiotropc effects of statins in cardiovascular disease. Vascular and Endovascular Surgery. 2010;44(4):241-251. https://doi.org/10.1177/1538574410362922
Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. International Journal of Cardiology. 2014;171(3):309-325. https://doi.org/10.1016/j.ijcard.2013.11.025
de Boer IH, Bakris G, Cannon CP. Individualizing Blood Pressure Targets for People with Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations. JAMA. 2018;319(13):1319-1320. https://doi.org/10.1001/jama.2018.0642
Barter PJ, Waters DD. Variations in time to benefit among clinical trials of cholesterol-lowering drugs. Journal of Clinical Lipidology. 2018;12(4):857-862. https://doi.org/10.1016/j.jacl.2018.04.006